Anzeige
Mehr »
Montag, 15.09.2025 - Börsentäglich über 12.000 News
Diese Aktie meldet Mega-Deal: Nokia & Ericsson an Bord!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
13.08.Merck begins 8% workforce purge, laying off 58 at its New Jersey HQ
12.08.Eli Lilly pledges vigorous defense as Texas sues over alleged drug kickbacks
12.08.Biohaven trashes troriluzole in OCD after asset bungles phase 3 trial
12.08.AbbVie plans $195M API plant in Illinois as part of US investment campaign
12.08.Endo returns to its roots, building on 'Bent Carrot' campaign for fresh Xiaflex push
12.08.Pfizer and Astellas' Padcev, plus Keytruda, delivers 'breakthrough' win in new bladder cancer use
12.08.In wake of Trump's request for direct drug sales, BlinkRx debuts off-the-shelf DTC platform for pharmas
12.08.Summit skips routine quarterly investor call as deal rumors swirl
12.08.FDA may not renew Pfizer's pediatric COVID shot authorization, prompting potential complication for child vaccinations this fall
12.08.Medical device, pharma packaging specialist Sanner makes CEO change amid growth push
11.08.Cold Chain Technologies to eliminate 82 jobs at HQ in Massachusetts
09.08.Vinay Prasad is back at the FDA after last month's surprise ouster. Will he stay this time?
08.08.CDC campaign targeting substance use, mental health tells teens to 'Free Your Mind'
08.08.Amid excitement over Yeztugo, Gilead sees continued erosion of CAR-T sales
08.08.FDA restricts bluebird bio gene therapy Skysona after blood cancer reports
08.08.GSK collects $320M as BioNTech, Pfizer settle mRNA patent spat with CureVac
08.08.Fierce Pharma Asia-Sanofi pulls Praluent in China; Trump updates drug tariff threat; An early-stage capital crunch
08.08.Is Trump's MFN pricing order more bark than bite?
08.08.Trial results set up AbbVie, Genmab's Epkinly for key expansion in follicular lymphoma
07.08.Amid pharma's US investment spree, FDA unveils new program to streamline domestic plant build-outs
07.08.Novo Nordisk's US marketing head Ulrich Otte steps down
07.08.CorMedix expands infectious disease portfolio with $300M acquisition of Melinta
07.08.Amid MFN talks, Lilly chief warns US adoption of international drug prices could bring 'worst of two worlds'
07.08.FDA tightens label of Valneva's chikungunya vaccine, lifts pause in older adults
07.08.Vor Bio hires commercial chief, reuniting ex-Sarepta colleagues in freshly rebuilt C-suite